Dr Wilf Keller is stepping down as president and CEO of Genome Prairie and devoting his full attention to his role as president and CEO of Ag-West Bio. Keller was instrumental in attracting Genome Prairie to the city when it restructured in 2005 and has held the dual roles for more than two years. He will be replaced at Genome Prairie by Dr David Gauthier on an acting basis. Gauthier is a private consultant specializing in investment and technology. He has previously held senior positions at several organizations including Performance Plants (director of business development), Foragen Technologies Management Inc (VP), Industrial Research Assistance Program (regional director) and most recently Entrepreneurial Foundation of Saskat-chewan (CEO)….